AKT1 and gestational diabetes: Results show reduced hENT2-adenosine transport and expression, and SLC29A2 (for hENT2) promoter activity, and reduced IR-A/IR-B expression ratio paralleled by p42/44mapk/Akt activation ratios in GDM, all phenomena reversed by insulin.